Literature DB >> 32493327

Active and latent tuberculosis in refugees and asylum seekers: a systematic review and meta-analysis.

Raquel Proença1, Fernanda Mattos Souza1, Mayara Lisboa Bastos1, Rosângela Caetano1, José Ueleres Braga1,2, Eduardo Faerstein1, Anete Trajman3,4,5.   

Abstract

BACKGROUND: In 2018, there were 70.8 million refugees, asylum seekers and persons displaced by wars and conflicts worldwide. Many of these individuals face a high risk for tuberculosis in their country of origin, which may be accentuated by adverse conditions endured during their journey. We summarised the prevalence of active and latent tuberculosis infection in refugees and asylum seekers through a systematic literature review and meta-analyses by country of origin and host continent.
METHODS: Articles published in Medline, EMBASE, Web of Science and LILACS from January 2000 to August 2017 were searched for, without language restriction. Two independent authors performed the study selection, data extraction and quality assessment. Random effect models were used to estimate average measures of active and latent tuberculosis prevalence. Sub-group meta-analyses were performed according to country of origin and host continent.
RESULTS: Sixty-seven out of 767 identified articles were included, of which 16 entered the meta-analyses. Average prevalence of active and latent tuberculosis was 1331 per 100 thousand inhabitants [95% confidence interval (CI) = 542-2384] and 37% (95% CI = 23-52%), respectively, both with high level of heterogeneity (variation in estimative attributable to heterogeneity [I2] = 98.2 and 99.8%). Prevalence varied more according to countries of origin than host continent. Ninety-one per cent of studies reported routine screening of recently arrived immigrants in the host country; two-thirds confirmed tuberculosis bacteriologically. Many studies failed to provide relevant information.
CONCLUSION: Tuberculosis is a major health problem among refugees and asylum seekers and should be given special attention in any host continent. To protect this vulnerable population, ensuring access to healthcare for early detection for prevention and treatment of the disease is essential.

Entities:  

Keywords:  Forced migration; Global health; Latent tuberculosis infection; Mycobacterium tuberculosis; Prevalence

Year:  2020        PMID: 32493327     DOI: 10.1186/s12889-020-08907-y

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  5 in total

1.  Pediatric Tuberculosis Disease during Years of High Refugee Arrivals: A 6-Year National Prospective Surveillance Study.

Authors:  Nora Fritschi; Axel J Schmidt; Jürg Hammer; Nicole Ritz
Journal:  Respiration       Date:  2021-07-29       Impact factor: 3.580

2.  Factors associated with latent tuberculosis among international migrants in Brazil: a cross-sectional study (2020).

Authors:  Sonia Vivian de Jezus; Thiago Nascimento do Prado; Ricardo Alexandre Arcêncio; Keila Cristina Mascarello; Carolina Maia Martins Sales; Maysa Mabel Fauth; Nahari de Faria Marcos Terena; Raphael Florindo Amorim; Vania Maria Silva Araujo; Miguel Angel López Aragón; Ethel Leonor Noia Maciel
Journal:  BMC Infect Dis       Date:  2021-06-01       Impact factor: 3.090

Review 3.  Perioperative management of patients with suspected or confirmed COVID-19: review and recommendations for perioperative management from a retrospective cohort study.

Authors:  Hua Zheng; Harry L Hébert; Athanasia Chatziperi; Weihua Meng; Blair H Smith; Jing Yan; Zhiqiang Zhou; Xianwei Zhang; Ailin Luo; Liuming Wang; Wentao Zhu; Junbo Hu; Lesley A Colvin
Journal:  Br J Anaesth       Date:  2020-09-04       Impact factor: 9.166

4.  Spatio-temporal epidemiology of the tuberculosis incidence rate in Iran 2008 to 2018.

Authors:  Behzad Kiani; Amene Raouf Rahmati; Robert Bergquist; Soheil Hashtarkhani; Neda Firouraghi; Nasser Bagheri; Elham Moghaddas; Alireza Mohammadi
Journal:  BMC Public Health       Date:  2021-06-07       Impact factor: 3.295

5.  Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees.

Authors:  Ghassan Ilaiwy; David W Dowdy
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.